CIK 0001010086
- Accelerated filer
SIGA TECHNOLOGIES INC
Sign in to watch- Ticker
- SIGA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133864870
- Phone
- +1 212-672-9100
- Business address
- 31 EAST 62ND STREET, NEW YORK, NY, 10065
- Former names
- SIGA PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-04-17 | CONSTANCE THOMAS E Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2018-04-16 | SAVAS PAUL G Director | Option exercise | +10,000 | $3.53 | $35K | 213,504 |
| 2018-04-16 | SAVAS PAUL G Director | Shares withheld for taxes | −5,657 | $6.24 | $35K | 207,847 |
| 2018-04-16 | SAVAS PAUL G Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2017-11-13 | ROSE ERIC A MD Executive Chairman | Option exercise | +97,785 | $3.53 | $345K | 782,713 |
| 2017-11-13 | ROSE ERIC A MD Executive Chairman | Shares withheld for taxes | −49,446 | $4.47 | $221K | 733,267 |
| 2017-11-13 | ROSE ERIC A MD Executive Chairman | Option exercise · Stock-Settled Stock Appreciation Rights | −465,000 | 0 | ||
| 2017-11-10 | Hruby Dennis E VP & Chief Scientific Officer | Option exercise | +71,168 | $3.53 | $251K | 237,579 |
| 2017-11-10 | Hruby Dennis E VP & Chief Scientific Officer | Shares withheld for taxes | −29,439 | $4.60 | $135K | 208,140 |
| 2017-11-10 | Hruby Dennis E VP & Chief Scientific Officer | Option exercise · Stock-Settled Stock Appreciation Rights | −337,500 | 0 | ||
| 2017-06-08 | Hruby Dennis E VP & Chief Scientific Officer | Returned to the company · Stock Option (Right to buy) | −200,000 | $0.42 | $84K | 100,000 |
| 2017-06-08 | Hruby Dennis E VP & Chief Scientific Officer | Grant or award · Restricted Stock Units | +25,000 | 25,000 | ||
| 2017-05-23 | Marshall Joseph W III Director | Grant or award · Restricted Stock Units | +15,000 | 15,000 | ||
| 2017-05-23 | KINDLER JEFFREY B Director | Grant or award · Restricted Stock Units | +15,000 | 15,000 | ||
| 2017-05-23 | BAYER MICHAEL J Director | Grant or award · Restricted Stock Units | +15,000 | 15,000 | ||
| 2017-05-23 | SAVAS PAUL G Director | Grant or award · Restricted Stock Units | +15,000 | 15,000 | ||
| 2017-05-23 | Plansky Michael C. Director | Grant or award · Stock Option (Right to buy) | +25,000 | 25,000 | ||
| 2017-05-23 | Plansky Michael C. Director | Grant or award · Restricted Stock Units | +15,000 | 15,000 | ||
| 2017-05-23 | CONSTANCE THOMAS E Director | Grant or award · Restricted Stock Units | +15,000 | 15,000 | ||
| 2017-05-23 | Antal James Director | Grant or award · Restricted Stock Units | +15,000 | 15,000 |
Page 20 of 28 · 558 trades